QNTM · Quantum Biopharma Ltd.
$3.80
+0.57 (+17.65%)
At close · Aug 14
Market Cap
$24.43M
Shares
6.43M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-14 | — | |
| 6-K | 2026-08-13 | 2026-06-30 | |
| 6-K | 2026-08-10 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-18 | — | |
| 6-K | 2026-05-07 | — | |
| 6-K | 2026-05-06 | 2026-03-31 | |
| 6-K | 2026-04-22 | — | |
| 6-K | 2026-04-02 | — | |
| 6-K | 2026-04-01 | — | |
| 6-K | 2026-03-30 | — | |
| 6-K | 2026-03-27 | — | |
| 6-K | 2026-03-26 | — | |
| 20-F | 2026-03-26 | 2025-12-31 | |
| 6-K | 2026-03-23 | — | |
| 6-K | 2025-12-23 | — | |
| 6-K | 2025-12-22 | 2025-12-19 | |
| 6-K | 2025-12-22 | — | |
| 6-K | 2025-12-22 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-28 | 2025-11-27 | |
| 6-K | 2025-11-26 | — | |
| 6-K | 2025-11-25 | — | |
| 6-K | 2025-11-07 | — | |
| 6-K | 2025-11-06 | 2025-09-30 | |
| 6-K | 2025-11-03 | 2025-10-31 | |
| 6-K | 2025-10-29 | 2024-06-07 | |
| 6-K | 2025-10-29 | 2024-09-25 | |
| 6-K | 2025-10-29 | 2024-02-06 | |
| 6-K | 2025-10-23 | — | |
| 6-K | 2025-10-20 | — | |
| 6-K | 2025-10-14 | — | |
| 6-K | 2025-10-08 | — | |
| 6-K | 2025-10-03 | — | |
| 6-K | 2025-10-02 | — | |
| 6-K | 2025-10-01 | — | |
| 6-K | 2025-09-29 | — | |
| 6-K | 2025-09-24 | — | |
| 6-K | 2025-09-18 | — | |
| 6-K | 2025-09-12 | — | |
| 6-K | 2025-09-10 | — | |
| 6-K | 2025-08-21 | — | |
| 6-K | 2025-08-11 | — | |
| 6-K | 2025-08-08 | — | |
| 6-K | 2025-08-07 | — | |
| 6-K | 2025-08-07 | 2025-06-30 | |
| 6-K | 2025-08-05 | — | |
| 6-K | 2025-08-04 | — |
Showing 1–50 of 294 filings
Key facts
CIK
1771885
CUSIP
74764Y205
13F (30d)
25 filings
25 filers
Visit website
Investor relations